Barclays Issues Pessimistic Forecast for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its price target cut by Barclays from $76.00 to $43.00 in a research note published on Friday,Benzinga reports. They currently have an overweight rating on the stock.

Other equities research analysts have also issued reports about the company. KeyCorp began coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Deutsche Bank Aktiengesellschaft lifted their target price on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Royal Bank of Canada decreased their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday, November 18th. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $79.67.

Acadia Healthcare Price Performance

ACHC opened at $39.99 on Friday. The business has a fifty day moving average of $53.36 and a 200 day moving average of $64.32. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market cap of $3.71 billion, a P/E ratio of 13.11, a PEG ratio of 1.69 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. During the same quarter in the previous year, the business earned $0.91 EPS. Acadia Healthcare’s revenue was up 8.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Wellington Management Group LLP grew its stake in Acadia Healthcare by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after buying an additional 1,266,384 shares during the last quarter. William Blair Investment Management LLC grew its stake in Acadia Healthcare by 20.7% during the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after buying an additional 604,070 shares during the last quarter. State Street Corp grew its stake in Acadia Healthcare by 3.5% during the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after buying an additional 95,613 shares during the last quarter. Point72 Asset Management L.P. grew its stake in Acadia Healthcare by 0.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock worth $144,753,000 after buying an additional 12,470 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in Acadia Healthcare by 0.9% during the 3rd quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock worth $102,320,000 after buying an additional 14,197 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.